To compare the prognostic performance of the MVFC‐identified tumor mutations and known biomarkers including post‐operative AFP and DCP [4, 23], we first used univariate cox analysis to screen clinical features and biomarkers with prognostic value. Here, AFP is linked to neoplasm.